|
|
|
|
Research Article
|
|
Effect of Morinda citrifolia (Noni) Fruit Juice on Antioxidant, Hematological and Biochemical Parameters in N-Methyl-N-Nitrosourea(NMU) Induced Mammary Carcinogenesis in Sprague-Dawley Rats |
|
Mani Saminathan,
Ram Bahal Rai,
Kuldeep Dhama,
Babu Lal Jangir,
Subramaniyam Suresh,
Gopikunte Jayaramaiah Ranganath,
Inbaraj Sophia,
Kuppusamy Karuppanasamy,
Singaram Barathiraja
and
Arumugam Gopalakrishnan
|
|
|
ABSTRACT
|
N-Methyl-N-Nitrosourea (NMU) is a highly specific mammary gland carcinogen
that act directly and does not require metabolic activation. The novel medicinal
plant Morinda citrifolia, also called as Noni, has broad therapeutic
effects such as antibacterial, antiviral, antifungal, anticancer, analgesic,
anti-inflammatory, anti-oxidant and immune enhancing effects. The present study
was conducted to assess the beneficial effects of M. citrifolia fruit
juice on antioxidant, hematological and biochemical alterations caused by NMU
induced mammary carcinogenesis in Sprague-Dawley rats. The rats were divided
into five groups viz., vehicle control group-A (n = 8), M. citrifolia
control group-B (n = 8), NMU control group C (n = 15), M. citrifolia prevention
group-D (n = 15) and M. citrifolia treatment group-E (n = 15). By the
end of the 28 weeks experimental period all the animals were euthanized, blood
was collected by heart puncture. M. citrifolia treatment significantly
(p<0.05) increased the anti-oxidant enzymes such as catalase, superoxide
dismutase and significantly (p<0.05) decreased the lipid peroxidation activity
when compared to NMU control group-C. M. citrifolia exhibited a preventive
effect against anaemia, lymphocytosis and neutrophilia in group-D and group-E
when compared to group-C. Biochemical analyses showed normal levels of enzymes
of liver and kidney in M. citrifolia treated groups- B, D and E rats,
whereas NMU control group-C showed significant (p<0.05) decrease in albumin
and total protein levels. These findings indicate that M. citrifolia fruit
juice did not show any hepatotoxic or nephrotoxic effects. It was concluded
that the M. citrifolia fruit juice ameliorates the adverse effects of
NMU carcinogenesis and could be useful to treat mammary tumours in humans and
animals.
|
|
|
|
How
to cite this article:
Mani Saminathan, Ram Bahal Rai, Kuldeep Dhama, Babu Lal Jangir, Subramaniyam Suresh, Gopikunte Jayaramaiah Ranganath, Inbaraj Sophia, Kuppusamy Karuppanasamy, Singaram Barathiraja and Arumugam Gopalakrishnan, 2014. Effect of Morinda citrifolia (Noni) Fruit Juice on Antioxidant, Hematological and Biochemical Parameters in N-Methyl-N-Nitrosourea(NMU) Induced Mammary Carcinogenesis in Sprague-Dawley Rats. International Journal of Pharmacology, 10: 109-119. DOI: 10.3923/ijp.2014.109.119 URL: https://scialert.net/abstract/?doi=ijp.2014.109.119
|
|
|
Received: January 10, 2014;
Accepted: April 17, 2014;
Published: June 09, 2014
|
|
INTRODUCTION
Experimentally induced carcinogenesis models by using various chemicals in
laboratory animals are widely used to study the biology of cancers and for developing
evaluateing the cancer prevention strategies. The most commonly used chemical
carcinogenic agents are 3-methyl chloranthracene (MCA), 7, 12-dimethyl benzanthracene
(DMBA), N-Methyl-N-Nitrosourea (NMU), diethylnitrosoamine (DEN) and azoxymethane
(AOM) (Zarbl et al., 1985; Russo
et al., 1990; Thompson et al., 1995;
Mehta, 2000; Kubatka et al.,
2003; Roomi et al., 2005). NMU is a directly
acting carcinogen that does not require the metabolic activation steps in order
to form DNA adducts and has a very short half-life. The molecular basis for
NMU induced carcinogenesis is direct alkylation of DNA, thereby causing point
mutations in codon 12 of the Ha-ras-1 gene (Zarbl et
al., 1985; Chan et al., 2005; Perse
et al., 2009). NMU is a highly specific carcinogen for the mammary
gland but it also causes tumours in other organs such as prostate, pancreas,
liver, spleen, kidneys and lungs. NMU induced mammary tumours are more estrogen
dependent, aggressive, locally invasive and they are capable to metastasize
(Gusterson and Williams, 1981; Russo
et al., 1990; Thompson et al., 1995;
Chan et al., 2005). Most widely used standard
dose for mammary tumour carcinogenesis is 50 mg NMU kg-1 body weight
administered intraperitoneally between 50-60 days of age. Moreover, NMU has
been used to test whether animals are predisposed to neoplasia or susceptible
to mutagens (Gusterson and Williams, 1981; Thompson
et al., 1995; Perse et al., 2009).
India has a rich heritage of medicinal plants and herbs and a large number
of plant extracts have been reported to be having high utility against several
diseases and disorders including of cancers. In recent times, thousands of herbs
and their preparations are being studied worldwide to identify their pharmacologically
active components and scientific validation purposes which are playing crucial
role in propagating and popularizing the use of wonderful drugs/medicines (Mahima
et al., 2012, 2013; Singh,
2012; Tiwari et al., 2012; Dhama
et al., 2013; Saminathan et al., 2013).
The list of useful plants goes endless but most commonly used herbal medicinal
plants include Azadirachta indica (neem), Tinospora cardifolia
(giloy), Astragalus membranaceus, Withania somnifera (ashwagandha), Emblica
officinalis (amla), Ocimum sanctum (tulsi), Piper longum (pipali),
Aloe vera, Allium sativum (garlic), Zingiber officinale, (ginger),
Curcuma longa, (turmeric) etc., (Mahima et al.,
2012; Tiwari et al., 2012, 2014a,
b; Dhama et al., 2013).
An edible and tropical plant Morinda citrifolia L. has been widely used
by polynesians in folk medicine for more than 2,000 years. It is commonly known
as great morinda, Indian mulberry, nunaakai and Noni in India, Ba Jitianin in
China, dog dumpling in Barbados, mengkudu in Indonesia and Malaysia, Nono in
Tahiti; painkiller bush in the Caribbean; cheese fruit in Australia and beach
mulberry or Noni in Hawaii (Morton, 1992; Wang
et al., 2002; Serafini et al., 2011;
Singh, 2012). M. citrifolia belongs to coffee
family, Rubiaceae, made up of around 80 species. It is a short tropical
evergreen plant and is found in open coastal and forest areas upto 1300 feet
above sea level. It is native to the Pacific islands, Hawaii, Caribbean, Asia
and Australia (Morton, 1992; Brown,
2012; Singh, 2012). In Southern India, M. citrifolia
is found in the coastal regions of the Tamil Nadu and Kerala and also in the
Mangalore area of Karnataka.
Different parts of the Noni plant have been traditionally used for treatment
of various complaints for their therapeutic activities, including hypotensive
action, analgesia, antibacterial effects, antituberculosis, anti-inflamatory
action and antioxidant effects. It is also used for curing osteoporosis and
auditory improvement, wound healing, antiviral activity, anticataract, antigout,
antifungal, neuronal protective, antidiabetes, anti-postoperative nausea and
vomiting. Noni is also found useful in cancer chemoprevention and treatment
of cancers due to its anti-angiogenesis effects and immune stimulation (Morton,
1992; Wang and Su, 2001; Wang
et al., 2002; Anitha and Mohandass, 2006;
Dussossoy et al., 2011; Serafini
et al., 2011; Brown, 2012; Singh,
2012; Saminathan et al., 2013). It regulates
cell function and regeneration of damaged cells. The Noni juice had been commercialized
in the USA as functional food products in 1990s and is increasingly
distributed all over the world (Brown, 2012; Singh,
2012). The pharmacologically active compounds derived from M. citrifolia
fruits, leaves and roots are nowadays available as readymade capsules, teas
and juices, the fruit juice being the most popular. Noni fruit contains alkaloids,
scopoletin, damnacanthal and lots of other molecules, as a result the consumption
of noni juice is currently high, not only in US but also in Japan, Europe and
India (Su et al., 2005; Liu
et al., 2007; Ikeda et al., 2009;
Singh, 2012).
The effects of M. citrifolia fruit juice on the antioxidant, hematological
and biochemical alterations caused by N-Methyl-N-Nitrosourea (NMU) induced mammary
carcinogenesis in Sprague-Dawley rats have not been recorded yet. Therefore,
the present study was conducted to investigate the biological effects of M.
citrifolia fruit juice in preventing and eliminating the adverse effects
of NMU induced carcinogenesis by evaluating the in vivo antioxidant effects
on blood and to investigate the safety of M. citrifolia by haematology
and serum biochemical parameters.
MATERIALS AND METHODS
Animals: This experiment was approved by the Institute Animal Ethics
Committee (IAEC) of Indian Veterinary Research Institute (IVRI), Izatnagar,
India and Committee for the Purpose of Control and Supervision of Experiments
on Animals (CPCSEA) before its commencement. The guiding principles in the care
and use of laboratory animals together with those described in the declaration
of Helsinki and Indian standards were strictly adhered to in the conduct of
all the experimental procedures. The out bred, female Sprague-Dawley rats, weighing
25-30 g were obtained from laboratory animal facility, Central Drug Research
Institute (CDRI), Lucknow, India at 3 weeks of age. The rats were housed in
polypropylene cages in the experimental animal house under environmentally controlled
conditions (temperature 25°C±2°C, relative humidity 30-70%) with
a 12/12 h light/dark cycle. The rats were provided with standard rodent pelleted
feed procured from Aashirwad Industries, Chandigarh (India) and water ad
libitum. The animals were acclimatized for one week before the commencement
of experiments.
Experimental induction mammary tumours: N-Methyl-N-Nitrosourea (NMU)
(Sigma Aldrich, USA) was used as the chemical carcinogen. The NMU injection
vials were wrapped with aluminium foil and kept in ice because NMU is sensitive
to light and humidity. The NMU was dissolved immediately prior to its use in
4 mL of 0.9% NaCl solution and acidified to pH 4 with acetic acid in such a
way that each mL was containing 5 mg of NMU and was administered at the dose
rate of 50 mg kg-1 body weight intra-peritoneal (i/p) following all
necessary safety and sterile precautions. After dissolving, the NMU was used
within 20 min and then the next vial of carcinogen was prepared. The injections
were given along the ventral midline of the animal, half way between the third
and fourth pair of mammary glands. Three doses were administered at 50, 80 and
110 days of age (Gusterson and Williams, 1981; Thompson
et al., 1995; Perse et al., 2009).
Morinda citrifolia fruit juice: The fruit juice of Morinda
citrifolia was purchased from World Noni Research Foundation, Chennai. M.
citrifolia fruit juice was administered orally by gavage at a dose of 10%
solution of 5 mL rat -1day -1, in two divided doses.
Experimental design: A total of 61 rats were randomly divided into 5
groups (Group A, B, C, D and E). Group-A (n = 8) received only acidified saline
(NMU vehicle), pH 4.0 by intra-peritoneal (i/p) route and served as vehicle
control group. Group-B (n = 8) was administered with only M. citrifolia
fruit juice at a dose of 10% solution of 5 mL rat -1 day -1
in two divided doses orally by gavage throughout the experiment. The animals
were not administered with NMU for tumor induction and served as M. citrifolia
control group. Group-C (n = 15) received only NMU at the dose rate of 50
mg kg -1 body weight intraperitoneally (i/p) three doses at 50, 80
and 110 days of age. The animals were not treated with M. citrifolia
fruit juice and served as NMU control group. Group-D (n = 15) was administered
with NMU as same protocol followed in group C and M. citrifolia was administered
15 days before NMU administration and continued for whole the study period and
this group served as M. citrifolia prevention group. Group-E (n = 15)
was administered with NMU as same protocol followed in group C and after appearance
of palpable tumours, animals were treated with M. citrifolia fruit juice
and this group served as M. citrifolia treatment group (Table
1). The whole experiment duration was of 28 weeks.
Anti-oxidant activity estimation: Anti-oxidant status was assessed in
Red Blood Cells (RBC) hemolysate by estimation of catalase, superoxide dismutase
and lipid peroxidation activity at the termination of experiment as per Aebi
(1983), Marklund and Marklund (1974) and Shafiq-Ur-Rehman
(1984), respectively.
Haematology: Red Blood Cells (RBC), haemoglobin (Hb), Packed Cell Volume
(PCV), total White Blood Cells (WBC), Differential Leukocyte Count (DLC) and
thrombocyte count was estimated using an automated blood analyzer (Cell Dyn®
3700, Abbott Diagnostic, USA).
Serum biochemistry
Liver Function Test (LFT): Blood was collected in sterile vial without
anticoagulant for serum separation. Sera samples were analyzed for Liver Function
Test (LFT), biochemical parameters viz. total protein, albumin, alanine aminotransferases
(ALT/SGPT), aspartate aminotransferases (AST/SGOT) and alkaline phosphatase
(ALP) using standard commercial kits (Span diagnostics, India).
Kidney function test: Blood was collected in sterile vial without anticoagulant
for serum separation. Sera samples were analyzed for Blood Urea Nitrogen (BUN)
and creatinine using standard commercial kits (Span diagnostics, India).
Table 1: |
Details of experimental design |
 |
NMU dose used was 50 mg kg-1 b.wt, intra-peritoneal
at 50, 80 and 110 days of age (*), M. citrifolia fruit juice dose
used was 10% solution of 5 mL-1 rat-1 day-1
in two divided doses, orally by gavage (**) |
RESULTS
Oxidative stress related biochemical parameters
Effects on Lipid Peroxidation (LPO): The effects of M. citrifolia
treatment on lipid peroxidation (LPO) in RBC haemolysate of rats in different
groups are presented in Fig. 1. LPO levels were significantly
(p<0.05) increased (4.9±0.09 nmol MDA mL-1) in NMU control
group-C. M. citrifolia treatment significantly (p<0.05) decreased
the LPO levels in group-E by 3.40±0.09 nmol MDA mL-1. M.
citrifolia prevention group-D resulted in decreased LPO levels by 2.90±0.03
nmol MDA mL-1. The LPO values of M. citrifolia control group-B
was statistically significant (p<0.05) from vehicle control group-A, indicating
M. citrifolia was reducing the LPO levels in normal body.
Effects on catalase (CAT): The effects of M. citrifolia treatment
on catalase (CAT) in RBC hemolysate of rats in different groups are presented
in Fig. 2. The activity of CAT was significantly depleted
(10.41±0.43 μ mol of H2O2 min-1
mg-1 protein) in NMU control group-C. M. citrifolia treatment
significantly increased the CAT activity in group-E and by 29.74±0.59
μ mol of H2O2 min-1 mg-1 protein.
The CAT activity significantly increased in prevention group D by 45.70±0.88
μ mol of H2O2 min-1 mg-1 protein.
M. citrifolia control group B was statistically significant (p<0.05)
from vehicle control group-A in terms of catalase activity, indicating M.
citrifolia was increasing the CAT levels in normal body.
Effects on superoxide dismutase (SOD): The values of the superoxide
dismutase (SOD) activity of RBC hemolysate in control and experimental rats
are presented in the Fig. 3. SOD activity was significantly
(p<0.05) decreased by 14±1.00 units g-1 of protein in rats
exposed to NMU control group-C. M. citrifolia treatment significantly
(p<0.05) increased the SOD activity in group-E by 32±1.1 units g-1
of protein. M. citrifolia used for prevention significantly (p<0.05)
increased the SOD activity by 41±0.85 units g-1 of protein
in group-D. The SOD levels in M. citrifolia control group B was statistically
significant (p<0.05) from vehicle control group-A, indicating M. citrifolia
was increasing the SOD levels in normal body.
Haematology
Red Blood Cells (RBC), hemoglobin (Hb) and Packed Cell Volume (PCV) count:
The NMU control group-C rats exhibited significant (p<0.05) decrease in RBC,
Hb and PCV levels indicating erythropaenia or anaemia when compared to group
A, B, D and E rats.
|
Fig. 1: |
Bar diagram showing effect of M. citrifolia fruit juice
on Lipid Peroxidation (LPO) in different experimental groups |
|
Fig. 2: |
Bar diagram showing effect of M. citrifolia fruit juice
on catalase in different experimental groups |
|
Fig. 3: |
Bar diagram showing effect of M. citrifolia fruit juice
on superoxide dismutase (SOD) in different experimental groups |
M. citrifolia treated prevention group-D and treatment group-E rats
showed normal values of RBC, Hb and PCV (Table 2).
Thrombocyte count: Platelet count was significantly (p<0.05) decreased
in NMU control group-C rats when compared to group A, B, D and E rats. Whereas,
M. citrifolia treated prevention group-D and treatment group-E rats showed
normal levels of platelet count (Table 2).
Table 2: |
Effect of M. citrifolia fruit juice on hematological
values in different experimental groups (Mean±SEM) |
 |
Mean±SEM values with superscript b indicates
the significant differences (p<0.05) between group-C and other groups,
Group A: vehicle control, Group B: M.citrifolia control, Group C:
NMU control, Group D: M.citrifolia Prevention and Group E: M.citrifolia
treatment |
Table 3: |
Effect of M. citrifolia fruit juice on liver enzyme
levels in different experimental groups (Mean±SEM) |
 |
Mean±SEM values with superscript b indicates
the significant differences (p<0.05) between group-C and other groups,
Group A: vehicle control, Group B: M.citrifolia control, Group C:
NMU control, Group D: M.citrifolia Prevention and Group E: M.citrifolia
treatment |
Table 4: |
Effect of M. citrifolia fruit juice on kidney function
in different experimental groups (Mean±SEM) |
 |
Mean±SEM values with superscript a indicates
no significant differences (p<0.05) between the groups, Group A: vehicle
control, Group B: M.citrifolia control, Group C: NMU control, Group
D: M.citrifolia Prevention and Group E: M.citrifolia treatment |
Total white blood cell (TLC) and Differential Leukocyte Count (DLC):
The NMU control group-C rats showed significant (p<0.05) increase in lymphocytes
and neutophils indicating lymphocytosis and neutrophilia, respectively, when
compared to group B, D and E rats. M. citrifolia treated prevention group-D
and treatment group-E rats showed significant decrease in lymphocytes and neutrophils
and exhibited normal WBC levels (Table 2).
Serum biochemistry
Liver function test (LFT): The effects of M. citrifolia treatment
on liver in terms of serum AST, ALT, ALP, total protein and albumin of rats
in different groups are presented in Table 3. M. citrifolia
treated groups-B, D and E rats showed no significant differences in the
serum AST, ALT and ALP levels as compared to control groups-A and C. Group-C
rats showed significant (p<0.05) decrease in albumin and total protein levels
indicating hypoproteinemia in comparison to groups-A, B, D and E rats, whereas
M. citrifolia treated groups-D and E rats showed normal levels of albumin
and total protein.
Kidney function test: The effects of M. citrifolia treatment
on kidney in terms of serum BUN and creatinine levels of rats in different groups
are presented in Table 4. No significant differences in serum
BUN and creatinine levels were observed in rats exposed to M. citrifolia
treatment as compared to control.
DISCUSSION
The N-Methyl-N-Nitrosourea (NMU) induced mammary tumours in rats mimics breast
cancer in human because the histological resemblance of mammary gland tumours
in rats, ovarian hormone dependant neoplasms, mammary ductal epithelial cells
in origin, highly malignant rat tumours resembles intra-ductal and infiltrating
ductal carcinomas in humans and altered expression of cyclin D1, erbB2 and TGFB
(Gusterson and Williams, 1981; Russo
et al., 1990; Thompson et al., 1995;
Chan et al., 2005). Therefore, the NMU induced
mammary tumours model has been widely used to evaluate the chemopreventive and
therapeutic agents against breast cancer in human (Mehta,
2000; Kubatka et al., 2003; Roomi
et al., 2005).
Oxidative stress has been suggested to contribute to the pathogenesis of carcinogenicity
and lipid peroxidation is one of the characteristic features of cancer (Halliwell,
2007; Klaunig et al., 2010). The reactive
intermediates, produced by oxidative stress, can alter the membrane bilayers
and cause the lipid peroxidation of polyunsaturated fatty acids (PUFA) leading
to the formation of lipoperoxyl radical (LOO●) which in turn,
reacts with a lipid to yield a lipid radical and a lipid hydroperoxide (LOOH).
LOOHs are unstable and they generate new peroxyl and alkoxy radicals and decompose
into secondary products (Halliwell and Chirico, 1993;
Gago-Dominguez et al., 2005). Malondialdehyde
(MDA) is formed during oxidative degeneration as a product of free oxygen radicals
which is accepted as an indicator of lipid peroxidation. MDA, the end product
of lipid peroxidation, was reported to be higher in cancer tissues than in non-diseased
organ (Nielsen et al., 1997; Marnett,
1999).
In the present study, LPO levels were significantly (p<0.05) increased in
NMU control group-C rats. M. citrifolia treatment significantly (p<0.05)
decreased the LPO levels in prevention group-D and treatment group-E rats. Antioxidants,
both enzymatic and non-enzymatic, are the first line of defence against free
radical induced toxicity. A redox balance between pro-oxidants and antioxidants
is essential for the normal cellular functioning (Nordberg
and Arner, 2001; Rahal et al., 2014). Impairment
in the ratio of oxidants and antioxidants initiates the patho-physiological
events that culminate in molecular and cellular damage to macromolecules and
vital organs (Valko et al., 2006). The antioxidant
enzymes SOD and CAT play an important role in reducing cellular stress. SOD
scavenges the superoxide radical by converting it to hydrogen peroxide and molecular
oxygen (Robinson, 1998), while CAT brings about the
reduction of hydrogen peroxides and protects higher tissues from the highly
reactive hydroxyl radicals (Brioukhanov and Netrusov, 2004).
In the present study, the activity of CAT was significantly depleted in NMU
control group-C rats. M. citrifolia treatment significantly increased
the CAT activity in prevention group-D and treatment group-E rats when compared
to NMU control. The SOD activity was significantly decreased in rats exposed
to only NMU. M. citrifolia treatment significantly (p<0.05) increased
the SOD activity in prevention group-D and treatment group-E. Noni juice has
excellent antioxidant activity which may guard individuals from oxygen free
radicals and lipid peroxidation induced damage. These findings were corresponded
with the observations of Wang and Su (2001) and Wang
et al. (2002), who estimated the in vitro Superoxide Anion
Radicals (SAR) and quenched Lipid Peroxides (LPO) scavenging activity of Tahitian
Noni Juice (TNJ) by Tetrazolium Nitroblue (TNB) assay and LMB assay, respectively.
TNJ showed a concentration dependent inhibition of both LPO and SAR. The SAR
scavenging activity of TNJ was 2.8 times that of vitamin C, 1.1 times that of
grape seed powder and 1.4 times that of Pycnogenol. These results confirmed
the antioxidant potential of TNJ by quenching the reactive oxygen free radicals.
Wang and Su (2001) and Wang et
al. (2002) also estimated the in vivo antioxidant activity of
noni juice against carbon tetrachloride (CCl4) induced liver injury
model in female SD rats. CCl4 is a hepatic carcinogen and potent
inducer of lipid hydroperoxidation. Administration of 10% of TNJ in drinking
water for a period of 12 days suppressed the levels of LPO and SAR in liver
to 20% and 50%, respectively, 3 h after administration of CCl4. Zin
et al. (2002) and Su et al. (2005)
reported that various parts of M. citrifolia (leaf, fruit and root) to
have antioxidative activities. When compared to either leaf or fruit the polar
and non-polar extracts of the root exhibited stronger antioxidative potential.
Anitha and Mohandass (2006) reported that oral administration
of 50 mg-1 Kg-1 day-1 of crude methanol extract
of M. citrifolia leaves for a period of 14 days significantly enhanced
the anti-oxidant enzymes, such as glutathione peroxidase (GSHPx), catalase (CAT)
and superoxide dismutase (SOD). Due to anti-oxidant activity there was reduction
in lymphoma in mice. Liu et al. (2007) have
reported that the antioxidative mechanism of Noni fruit juice was partially
attributable to the group of phenolic compounds, such as isoscopoletin, quercetin
and aesculetin in the EtOAc (ethanolic) extract. Ikeda et
al. (2009) observed that both Noni and coumarin derivatives have scavenging
activity on ROS such as superoxide (O-2), singlet oxygen
(1O2), hydroxyl radical (.OH) and peroxynitrite
(ONOO-) in a dose-dependent manner.
Cigarette smoke was reported to contain 227 possible carcinogens and each puff
of cigarette smoke contains 1x1017 oxidant molecules (Chow,
1993). Wang et al. (2009a, 2009b)
assessed the antioxidant activity of TNJ on plasma by estimating the SAR and
LPO levels in current cigarette smokers. The smokers were provided daily with
a dose of two ounces of TNJ twice a day for a period of 30 days. The LPO and
SAR levels in the TNJ group showed 23% reduction and 27% reduction, respectively,
when compared to placebo group. These results indicate that TNJ may guard individuals
from tobacco smoke free radical induced damage. West et
al. (2009a) also evaluated the antioxidant properties of roasted Noni
leaf infusion. The infusion has 2, 2-diphenylpicrylhydrazyl (DPPH) radical scavenging
activity which was higher when compared to green tea infusion. Thani
et al. (2010) recorded that the non-aqueous extracts from the leaves
of Thai Noni/Yor showed antioxidant properties, giving IC50 values of 0.20-0.35
mg mL-1. These results suggest that the leaves of M. citrifolia
could be preferred as a food supplement for its antioxidative activities
in epidermoid and cervical cancers over damnacanthal, rutin and scopoletin.
Dussossoy et al. (2011) showed that Nonis
anti-oxidant activities are possibly due to phenolic compounds, iridoids and
ascorbic acid. Serafini et al. (2011) investigated
the antioxidant activity of aqueous extract from M. citrifolia leaves
against lipid peroxidation, hydroxyl and nitric oxide induced radicals. West
et al. (2011) evaluated the antioxidant activity of M. citrifolia
seed extract. The seed extract exhibited significant antioxidant potential
against various types of free radical induced damage.
In the present study, hematological results showed significant (p<0.05)
decrease in RBC, Hb and PCV levels in NMU control group-C rats indicating a
tendency to develop erythropaenia or anaemia. The group-C rats also showed significant
(p<0.05) increase in lymphocytes indicating lymphocytosis with neutrophilia.
This indicates an inflammatory response in animals with large mammary tumours
(Table 2). These findings were in agreement with that of Perse
et al. (2009) and Hazilawati et al. (2010a),
who observed anaemia and neutrophilia in NMU administered rats. Saffhill
and Chaudhuri (1976) and Chang et al. (2012)
observed leukaemia in NMU administered rats.
The M. citrifolia prevention group-D and treatment group-E showed normal
levels of RBC, Hb and PCV. The M. citrifolia treated rats also showed
normal levels of lymphocytes and neutrophils count. These findings were in agreement
with Hazilawati et al. (2010a, 2010b),
who observed daily supplementation of M. citrifolia at the dose of 3000
mg kg-1 reduced the incidence of anaemia, neutrophilia and early
stage of leukaemia in rats.
The soluble hepatic enzymes like aspartate transferase (AST), alanine transferase
(ALT) and alkaline phosphatase (ALP) of blood-serum have been considered as
indicators of the hepatic dysfunction and damage. The increase in the activities
of these enzymes in serum is indicative of liver damage and thus causes alteration
in liver function. The hepatic cell damage exhibits good correlation with these
enzyme leakages. The possibility of M. citrifolia induced toxicity was
assessed in rats consuming the equivalent of a recommended dose in women (<3
oz daily) for most of their adult life. Serum levels of the hepatic enzymes
such as ALT, AST, ALP, albumin and total protein were examined in the M.
citrifolia treated rats, since these are considered markers of liver damage
in humans. In addition, serum blood urea nitrogen (BUN) and creatinine a marker
of renal function, was assessed. None of these markers in both liver and kidney
were not elevated and the levels are similar to the control group. These results
were supported histologically by the absence of toxin-induced damage to the
tissue sections of liver and kidney from the M. citrifolia treated group.
So long-term administration of M. citrifolia in the NMU induced mammary
tumour cases did not have any detectable adverse effects on the liver and kidney
tissues or markers assessed in this study.
These findings were almost similar to the observations of West
et al. (2006, 2009b, 2009c)
who performed with high doses of noni for shorter time periods, such as 90 mL
kg-1 daily for 3 months in rats and 750 mL-1 day-1
for 28 days in humans and showed lack of toxicity. Potterat
and Hamburger (2007), Westendorf et al. (2007)
and Hadijah et al. (2008) conducted the subchronic
toxicity of an aqueous extract of M. citrifolia fruit on SD male rats.
They found that a dosage of 20% juice (highest dose) was not safe for the rats
as it indicated renal as well as liver injuries. However, lower dosages of the
juice (5 and 10%) showed no significant changes, hence were considered safe.
Rosly et al. (2011) conducted subchronic oral
toxicity study to evaluate the safety of M. citrifolia in Sprague-Dawley
(SD) rats. The dose levels of 2000 (low dose) and 5000 (high dose) mg kg-1
b.w/day showed no toxicological significance. They concluded that the no-observed
adverse-effect level (NOAEL) for M. citrifolia was 5000 mg kg-1
body weight/day. However, few reports of hepatotoxicity do also exists. Yu
et al. (2011) observed acute hepatotoxicity after ingestion of M.
citrifolia juice in a 14-year-old boy. Millonig et
al. (2005) and Stadlbauer et al. (2005,
2008) reported hepatotoxicity after consumption of
M. citrifolia.
The possible mechanism of action responsible for anti-oxidant activity in NMU
induced mammary carcinogenesis is that Noni fruits contain precursor of xeronine
called proxeronine in significant quantity. Proxeronine is converted into xeronine
in the body by proxeroninase. The most important function of xeronine is to
regulate the rigidity and shape of specific proteins and is also a critical
metabolic coregulator. Xeronine will act on abnormal protein and make it fold
into its correct conformation that results in properly functioning protein (Heinicke,
1985). Noni has more than 160 phytochemical compounds. The major micronutrients
are alkaloids, phenolic compounds, proteins, organic acids, minerals and vitamins.
Among phenolic compounds, most important are anthraquinones damnacanthal, nordamnacanthal,
morindone, rubiadin-1-methyl ether, alizarin, rubiadin, aucubin, asperuloside
and scopoletin (Wang and Su, 2001; Su
et al., 2005; Liu et al., 2007; Potterat
and Hamburger, 2007; Ikeda et al., 2009;
Singh, 2012). The organic acids mainly are caproic
and caprylic acids, while the principal alkaloid is xeronine (Heinicke,
1985). The protein content of the fruit is surprisingly high and the main
amino acids are glutamic acid, aspartic acid and isoleucine. Noni has six major
substances namely anthraquinones, polysaccharides, epigallocatechin gallate
(EGCg), coumarins, monoterpenes and terpenoid compounds which have been shown
to fight cancer in different ways (Mathivanan et al.,
2005; Potterat and Hamburger, 2007).
CONCLUSION
The present study demonstrates for the first time the beneficial effects of
Morinda citrifolia fruit juice on the antioxidant, haematological and
biochemical alterations caused by N-Methyl-N-Nitrosourea (NMU) induced mammary
carcinogenesis in Sprague-Dawley rats. It was found that M. citrifolia
fruit juice ameliorates the effect of oxidative stress and brought the various
anti-oxidant enzymes to a normal level, indicating that M. citrifolia
fruit juice exhibits an anti-oxidant property in NMU induced mammary tumours
in rats. The administration of M. citrifolia fruit juice did not produce
any abnormalities in the Red Blood Cell (RBC), haemoglobin (Hb), Packed Cell
Volume (PCV), White Bcell (WBC), Differential Leukocyte Count (DLC) and platelet
count. M. citrifolia fruit juice also exhibited a preventive effect against
anaemia, lymphocytosis and neutrophilia. M. citrifolia fruit juice did
not show any hepatotoxicity and nephrotoxicity at a dose of 10% solution of
5 mL rat-1 day-1 in two divided doses, orally by gavage.
M. citrifolia fruit juice helped in maintaining the enzymes of liver
and kidney within the normal levels. In conclusion, M. citrifolia fruit
juice reduced the adverse effects caused by NMU induced mammary tumours and
didnt show any toxicity on liver
and kidney functions. However, further investigations are necessary in this
therapeutic direction to provide clarifications regarding the molecular mechanisms,
comprehensive phytochemical analysis, along with extensive study of the pharmacokinetics
and pharmacotherapeutic potentials of Noni.
ACKNOWLEDGEMENTS
The authors are thankful to the National Agricultural Innovation Project (NAIP),
Component-3, ICAR and to the Director, Joint director (Academic and Research)
of IVRI, Izatnagar, for providing necessary facilities to carry out this study.
|
REFERENCES |
1: Aebi, H.E., 1983. Catalase. In: Methods of Enzymatic Analysis, Bergmeyer, H.U. (Ed.). 3rd Edn., Verlag Chemie, Weinhem, pp: 276-286
2: Anitha, T. and S. Mohandass, 2006. Anti-oxidant activity of Morinda citrifolia on lymphoma-bearing mice. Ancient Sci. Life, 26: 85-88. Direct Link |
3: Brioukhanov, A.L. and A.I. Netrusov, 2004. Catalase and superoxide dismutase: Distribution, properties and physiological role in cells of strict anaerobes. Biochemistry, 69: 949-962. CrossRef | Direct Link |
4: Brown, A.C., 2012. Anticancer activity of Morinda citrifolia (Noni) fruit: A review. Phytother. Res., 26: 1427-1440. CrossRef | Direct Link |
5: Chan, M.M., X. Lu, F.M. Merchant, J.D. Iglehart and P.L. Miron, 2005. Gene expression profiling of NMU-induced rat mammary tumors: Cross species comparison with human breast cancer. Carcinogenesis, 26: 1343-1353. CrossRef | PubMed | Direct Link |
6: Chang, Y.C., J.D. Hsu, W.L. Lin, Y.J., Lee and C.J. Wang, 2012. High incidence of acute promyelocytic leukemia specifically induced by N-nitroso-N-methylurea (NMU) in Sprague-Dawley rats. Arch. Toxicol., 86: 315-327. CrossRef |
7: Liu, C.H., Y.R. Xue, Y.H. Ye, F.F. Yuan, J.Y. Liu and J.L. Shuang, 2007. Extraction and characterization of antioxidant compositions from fermented fruit juice of Morinda citrifolia (Noni). Agric. Sci. China, 6: 1494-1501. CrossRef | Direct Link |
8: Chow, C.K., 1993. Cigarette smoking and oxidative damage in the Lunga. Ann. N. Y. Acad. Sci., 686: 289-298. CrossRef | Direct Link |
9: Dhama, K., S. Mani, S. Chakraborty, R. Tiwari, A. Kumar, P. Selvaraj and R.B. Rai, 2013. Herbal remedies to combat cancers in humans and animals-A review. Int. J. Curr. Res., 5: 1908-1919. Direct Link |
10: Dussossoy, E., P. Brat, E. Bony, F. Boudard and P. Poucheret et al., 2011. Characterization, anti-oxidative and anti-inflammatory effects of Costa Rican Noni juice (Morinda citrifolia L.). J. Ethnopharmacol., 133: 108-115. CrossRef | Direct Link |
11: Gago-Dominguez, M., J.E. Castelao, M.C. Pike, A. Sevanian and R.W. Haile, 2005. Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol. Biomarkers Prev., 14: 2829-2839. CrossRef | PubMed |
12: Gusterson, B.A. and J.C. Williams, 1981. N-nitrosomethylurea-induced rat mammary tumours as models of human breast cancer. J. R. Soc. Med., 74: 56-59. PubMed | Direct Link |
13: Hadijah, H., A. Normah and S.A. Tarmizi, 2008. Thirteen-week toxicity study of mengkudu juice (Morinda citrifolia): Effect on the blood analysis. J. Trop. Agric. Food Sci., 36: 221-226. Direct Link |
14: Halliwell, B., 2007. Oxidative stress and cancer: Have we moved forward? Biochem. J., 401: 1-11. CrossRef | PubMed | Direct Link |
15: Halliwell, B. and S. Chirico, 1993. Lipid peroxidation: Its mechanism, measurement and significance. Am. J. Clin. Nutr., 57: 715S-724S. Direct Link |
16: Hazilawati, H., A.H. Hutheyfa, S.M. Rosly, S. Jasni, M.M. Noordin and S. Shanmugavelu, 2010. Haematological parameters of leukaemic rats supplemented with Morinda citrifolia. Med. J. Malaysia, 65: 125-126. Direct Link |
17: Hazilawati, H., H. Nursyuhada, A.H. Hutheyfa, S.M. Rosly, S. Shanmugavelu, S.M. Rosly and S. Jasni, 2010. Effects of Morinda citrifolia on early stage of leukemic in rats. Malay. Med. J., 65: 135-136.
18: Heinicke, R.M., 1985. The pharmacologically active ingredient of Noni. Pac. Trop. Bot. Garden Bull., 15: 10-14. Direct Link |
19: Ikeda, R., M. Wada, T. Nishigaki and K. Nakashima, 2009. Quantification of coumarin derivatives in Noni (Morinda citrifolia) and their contribution of quenching effect on reactive oxygen species. Food Chem., 113: 1169-1172. CrossRef | Direct Link |
20: Klaunig, J.E., L.M. Kamendulis and B.A. Hocevar, 2010. Oxidative stress and oxidative damage in carcinogenesis. Toxicol. Pathol., 38: 96-109. CrossRef | PubMed |
21: Kubatka, P., I. Ahlers, E. Ahlersova, E. Adamekova, P. Luk, B. Bojkova and M. Markova, 2003. Chemoprevention of mammary carcinogenesis in female rats by rofecoxib. Cancer Lett., 202: 131-136. CrossRef | Direct Link |
22: Mahima, A. Rahal, R. Deb, S.K. Latheef and H.A. Samad et al., 2012. Immunomodulatory and therapeutic potentials of herbal, traditional/indigenous and ethnoveterinary medicines. Pak. J. Biol. Sci., 15: 754-774. CrossRef | Direct Link |
23: Mahima, A.M. Ingle, A.K. Verma, R. Tiwari and K. Karthik et al., 2013. Immunomodulators in day to day life: A review. Pak. J. Biol. Sci., 16: 826-843. CrossRef | Direct Link |
24: Marklund, S. and G. Marklund, 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem., 47: 469-474. CrossRef | PubMed | Direct Link |
25: Marnett, L.J., 1999. Lipid peroxidation: DNA damage by malondialdehyde. Mutat. Res./Fundam. Mol. Mech. Mutagen., 424: 83-95. CrossRef | Direct Link |
26: Mathivanan, N., G. Surendiran, K. Srinivasan, E. Sagadevan and K. Malarvizhi, 2005. Review on the current scenario of Noni research: Taxonomy, distribution, chemistry, medicinal and therapeutic values of Morinda citrifolia. Int. J. Noni Res., 1: 1-16.
27: Mehta, R.G., 2000. Experimental basis for the prevention of breast cancer. Eur. J. Cancer, 36: 1275-1282. CrossRef | Direct Link |
28: Millonig, G., S. Stadlmann and W. Vogel, 2005. Herbal hepatotoxicity: Acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur. J. Gastroenterol. Hepatol., 17: 445-447. Direct Link |
29: Morton, J.F., 1992. The ocean-going noni, or Indian Mulberry (Morinda citrifolia, Rubiaceae) and some of its “colorful” relatives. Ecol. Bot., 46: 241-256. CrossRef | Direct Link |
30: Nielsen, F., B.B. Mikkelsen, J.B. Nielsen, H.R. Andersen and P. Grandjean, 1997. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin. Chem., 43: 1209-1214. PubMed | Direct Link |
31: Nordberg, J. and E.S.J. Arner, 2001. Reactive oxygen species, antioxidants and the mammalian thioredoxin system. Free Radic. Biol. Med., 31: 1287-1312. CrossRef | PubMed | Direct Link |
32: Perse, M., A. Cerar, R. Injac and B. Strukelj, 2009. N-methylnitrosourea induced breast cancer in rat, the histopathology of the resulting tumours and its drawbacks as a model. Pathol. Oncol. Res., 15: 115-121. CrossRef | Direct Link |
33: Potterat, O. and M. Hamburger, 2007. Morinda citrifolia (Noni) fruit-phytochemistry, pharmacology, safety. Planta Med., 73: 191-199. CrossRef | PubMed | Direct Link |
34: Rahal, A., A. Kumar, V. Singh, B. Yadav, R. Tiwari, S. Chakraborty and K. Dhama, 2014. Oxidative stress, prooxidants and antioxidants: The interplay. BioMed Res. Int., Vol. 2014. CrossRef | Direct Link |
35: Robinson, B.H., 1998. The role of manganese superoxide dismutase in health and disease. J. Inherit. Metab. Dis., 21: 598-603. CrossRef | Direct Link |
36: Roomi, M.W., N.W. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki and M. Rath, 2005. Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res., 7: R291-R295. CrossRef | PubMed |
37: Rosly, S.M., S. Shanmugavelu, M. Murugaiyah, H. Hadijah, S.A. Tarmizi, Y. Noridayusni and K. Subramaniam, 2011. Subchronic oral toxicity study of Morinda citrifolia (Mengkudu) in spraque Dawley rats. Pertanika J. Trop. Agric. Sci., 34: 341-349. Direct Link |
38: Russo, J., I.H. Russo, A.E. Rogers, M.J. Van Zwieten and B. Gusterson, 1990. Tumors of Mammary Gland. In: Pathology of Tumours in Laboratory Animals, Turusov, V. and M.U. Lyon (Eds.). IARC Scientific Publications, Lyon, France, pp: 47-78
39: Saffhill, R. and L. Chaudhuri, 1976. The presence of terminal deoxynucleotidyl transferase in the N-methyl-N-nitrosourea induced leukaemia in BDF1 mice and its effect on the accuracy of the DNA polymerases. Nucleic Acids Res., 3: 277-284. CrossRef | PubMed |
40: Serafini, M.R., R.C. Santos, A.G. Guimaraes, J.P.A. dos Santos and A.D.D.C. Santos et al., 2011. Morinda citrifolia Linn leaf extract possesses antioxidant activities and reduces nociceptive behavior and leukocyte migration. J. Med. Food, 14: 1159-1166. CrossRef | Direct Link |
41: Shafiq-Ur-Rehman, 1984. Lead-induced regional lipid peroxidation in brain. Toxicol. Lett., 21: 333-337. PubMed | Direct Link |
42: Singh, D.R., 2012. Morinda citrifolia L. (Noni): A review of the scientific validation for its nutritional and therapeutic properties. J. Diabetes Endocrinol., 3: 77-91. Direct Link |
43: Stadlbauer, V., P. Fickert, C. Lackner, J. Schmerlaib, P. Krisper, M. Trauner and R.E. Stauber, 2005. Hepatotoxicity of noni juice: Report of two cases. World J. Gastroenterol., 11: 4758-4760. Direct Link |
44: Stadlbauer, V., S. Weiss, F. Payer and R.E. Stauber, 2008. Herbal does not at all mean innocuous: The sixth case of hepatotoxicity associated with Morinda citrifolia (Noni). Am. J. Gastroenterol., 103: 2406-2407. CrossRef |
45: Su, B.N., A.D. Pawlus, H.A. Jung, W.J. Keller, J.L. McLaughlin and A.D. Kinghorn, 2005. Chemical constituents of the fruits of Morinda citrifolia (noni) and their antioxidant activity. J. Nat. Prod., 68: 592-595. Direct Link |
46: Thani, W., O. Vallisuta, P. Siripong and N. Ruangwises, 2010. Anti-proliferative and antioxidative activities of Thai noni/Yor (Morinda citrifolia Linn.) leaf extract. Southeast Asian J. Trop. Med. Public Health, 41: 482-489. PubMed |
47: Thompson, H.J., J.N. McGinley, K. Rothhammer and M. Singh, 1995. Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis, 16: 2407-2412. CrossRef | PubMed |
48: Tiwari, R., A. Latchumikanthan, R.K. Yadav and K. Dhama, 2012. Herbal and traditional botanical medicines for safeguarding animal and human health. Livestock Line, 6: 29-33.
49: Tiwari, R., S. Chakraborty, M. Saminathan, K. Dhama and S.V. Singh, 2014. Ashwagandha (Withania somnifera): Role in safeguarding health, immunomodulatory effects, combating infections and therapeutic applications: A review. J. Biol. Sci., 14: 77-94. Direct Link |
50: Tiwari, R., A.K. Verma, S. Chakraborty, K. Dhama and S.V. Singh, 2014. Neem (Azadirachta indica) and its potential for safeguarding health of animals and humans: A review. J. Biol. Sci., 14: 110-123. CrossRef | Direct Link |
51: Valko, M., C.J. Rhodes, J. Moncol, M. Izakovic and M. Mazur, 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 160: 1-40. CrossRef | PubMed | Direct Link |
52: Wang, M.Y., M.N. Lutfiyya, V. Weidenbacher-Hoper, G. Anderson, C.X. Su and B.J. West, 2009. Antioxidant activity of Noni juice in heavy smokers. Chem. Central J., Vol. 3. CrossRef |
53: Wang, M.Y., D. Nowicki and G. Anderson, 2002. Protective effect of Morinda citrifolia on hepatic injury induced by a liver carcinogen. Proceedings of the 93rd Annual Meeting of American Association for Cancer Research, Volume 43, April 6-10, 2002, San Francisco, CA., USA., pp: 477-477
54: Wang, M.Y., L. Peng, M.N. Lutfiyya, E. Henley, V. Weidenbacher-Hoper and G. Anderson, 2009. Morinda citrifolia (Noni) reduces cancer risk in current smokers by decreasing aromatic DNA adducts. Nutr. Cancer, 61: 634-639. CrossRef |
55: Wang, M.Y. and C. Su, 2001. Cancer preventive effect of Morinda citrifolia (Noni). Ann. N. Y. Acad. Sci., 952: 161-168. CrossRef | PubMed | Direct Link |
56: West, B.J., C.J. Jensen, A.K. Palu and S. Deng, 2011. Toxicity and antioxidant tests of Morinda citrifolia (Noni) seed extract. Adv. J. Food Sci. Technol., 3: 303-307.
57: West, B.J., C.J. Jensen and J. Westendorf, 2006. Noni juice is not hepatotoxic. World J. Gastroenterol., 12: 3616-3619. Direct Link |
58: West, B.J., S. Deng and A.K. Palu, 2009. Antioxidant and toxicity tests of roasted Noni (Morinda citrifolia) leaf infusion. Int. J. Food Sci. Technol., 44: 2142-2146. CrossRef | Direct Link |
59: West, B.J., C.X. Su and C.J. Jensen, 2009. Hepatotoxicity and subchronic toxicity tests of Morinda citrifolia (Noni) fruit. J. Toxicol. Sci., 34: 581-585. CrossRef | PubMed | Direct Link |
60: West, B.J., L.D. White, C.J. Jensen and A.K. Palu, 2009. A double-blind clinical safety study of Noni fruit juice. Pac. Health Dialog, 15: 21-32. PubMed |
61: Westendorf, J., K. Effenberger, H. Iznaguen and S. Basar, 2007. Toxicological and analytical investigations of Noni (Morinda citrifolia) fruit juice. J. Agric. Food Chem., 55: 529-537. CrossRef |
62: Yu, E.L., M. Sivagnanam, L. Ellis and J.S. Huang, 2011. Acute hepatotoxicity after ingestion of Morinda citrifolia (Noni Berry) juice in a 14-year-old boy. J. Pediatr. Gastroenterol. Nutr., 52: 222-224. CrossRef | Direct Link |
63: Zarbl, H., S. Sukumar, A.V. Arthur, D. Martin-Zanca and M. Barbacid, 1985. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature, 315: 382-385. CrossRef |
64: Zin, Z.M., A. Abdul-Hamid and A. Osman, 2002. Antioxidative activity of extracts from Mengkudu (Morinda citrifolia L.) root, fruit and leaf. Food Chem., 78: 227-231. CrossRef | Direct Link |
65: Saminathan, M., R.B. Rai, K. Dhama, R. Tiwari and S. Chakraborty et al., 2013. Systematic review on anticancer potential and other health beneficial pharmacological activities of novel medicinal plant Morinda citrifolia (Noni). Int. J. Pharmacol., 9: 462-492. Direct Link |
|
|
|
 |